Solution reagent kit MD07281

veterinary laboratoryclinicalRT-qPCR

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. Studies have identified a range of animals - such as cats, ferrets, hamsters, non-human primates, minks, tree shrews, raccoon dogs, fruit bats, and rabbits - that are susceptible and permissive to SARS-CoV-2 infection. Veterinary SARS-CoV-2 RT-qPCR Kit is designed for the in vitro detection of SARS-CoV-2 genomes. The kit is built to have the broadest possible detection profile whilst remaining specific to SARS-CoV-2. Thus, this kit has been designed for the specific (inclusivity) and exclusive (exclusivity) in vitro detection of this virus. The primers and probe sequences have very high (>95%) homology with a broad range of SARS-CoV-2 genomes based on a comprehensive bioinformatic analysis with all reference data within the NCBI and GISAID databases at the time of design. Due to the inherent instability of RNA viral genomes, it is not possible to guarantee the detection of all clinical isolates. This kit was meticulously designed and validated to meet the rigorous criteria of a quantitative assay. However, it is important to note that the provided Positive Control is not intended for quantification purposes. We recommend checking NZYtech website for the availability of a suitable Quantitative Standard for an accurate quantification. In alternative, commercially genomic RNA standards can also be used. If required, a complementary kit for the detection of an endogenous gene of the species from which samples are being extracted is available for purchase (see Vet, Food & Pharma).